Clinical Trials Directory

Trials / Completed

CompletedNCT03531307

Lactate Levels Correlates With Ki-67 in Brain Tumor Surgery

Lactate Levels at Beginning of Surgery Correlates With Ki-67 Labeling Index in Brain Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ricard Valero · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In neurosurgery, brain tumor patients show increased levels of lactate at the beginning of surgery. This has been related to malignancy. Ki-67 is a cell proliferation index used as a marker of tumor mitotic activity. This research aims to describe the correlation between lactate levels and the Ki-67 index in patients with brain tumor.

Detailed description

Lactate levels are used in the evaluation of perfusion status in critical care. Increases not related to a hypoperfusion state are observed in the patient with brain tumors. These increases have been related to type and tumor grade. This observation does not fully explain the variation within the same tumor grade. Ki-67 label index is a marker of mitotic activity that can be used as proliferation index. It has been associated with histologic grade and survival rate. Provides a quantitative measure of the tumor proliferation status. The investigators will perform a retrospective analysis of the clinical charts of patients after brain tumor resection. The study will address the relationship between baseline lactate levels and the proliferation index found in tissues biopsies.

Conditions

Interventions

TypeNameDescription
OTHERData correlationCorrelation between lactate levels and Ki-67 index

Timeline

Start date
2018-05-30
Primary completion
2018-07-30
Completion
2018-08-02
First posted
2018-05-21
Last updated
2019-02-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03531307. Inclusion in this directory is not an endorsement.